VxP Biologics, Inc. has launched as a new contract biologics manufacturer to provide development and manufacturing services at facilities in the US and India. Service areas include biologics process development and manufacturing, recombinant DNA engineering, cell line development, protein sciences (purification and crystallography), in-vivo pharmacology and toxicology, as well as cGMP antibody generation.

VxP Biologics was launched by VxP Pharma, headquartered in Indianapolis, Indiana. VxP Pharma was launched in 2014 as a platform to promote the combined services of the clients of CRO Solutions, a sales representation agency representing contract research organizations and CMOs from a business development and marketing standpoint, under a single brand. VxP offers its services to research and development scientists at pharma and biotech companies worldwide, and has a staff of full-time business development representatives covering all major markets, as well as inside sales, technical support, internet marketing, and operations support.

Source: VxP Biologics